ASH 2010 Conference Coverage

Exercise Before Lung Cancer Surgery Greatly Reduces Complications

Researchers conducted a systematic literature search to identify studies investigating the effectiveness of preoperative exercise on outcomes among oncology patients undergoing surgery.

Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies

A review of management approaches to Hodgkin lymphoma in Europe vs the United States/North America demonstrates that although some differences exist, worldwide studies that would enhance patient outcomes are feasible.

Zinc Sulfate Improves Chemotherapy-Induced Mucositis Outcomes in Leukemia

Results of a triple-blind study demonstrate effectiveness of zinc sulfate in preventing chemotherapy-induced mucositis or reducing its incidence and severity in patients with leukemia receiving chemotherapy.

5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy

A report from a phase 3 study on the 5-year failure-free survival of women with endometrial cancer treated with radiation therapy alone vs chemoradiotherapy plus adjuvant chemotherapy.

Travel Distance to Prostate Cancer Treatment Influences Treatment Choice 

Long-distance travel was more strongly associated with definitive prostate SBRT use, researchers found.

Sexual Aids and Resources Not Readily Available at Cancer Centers

Most centers reported having no sexual aids available for patients, according to researchers.

Cisplatin-Induced Adverse Events in Osteosarcoma Not Improved With Pantoprazole

This phase 2 study sought to determine whether concurrent pantoprazole would improve cisplatin-induced ototoxicity and nephrotoxicity in younger patients with osteosarcoma.

Treatment-free remission of chronic myeloid leukemia possible after second-line nilotinib

1. Phase 2, open-label study results suggest that treatment-free remission (TFR) of chronic myeloid leukemia (CML) for ≥48 weeks can be reached by over half of patients who have reached deep molecular response (DMR) after ceasing second-line nilotinib treatment. 2. The authors suggest that for patients who do not reach sustained DMR with imatinib, changing []

New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment

Publication of the JNC 8 introduces a lower threshold for initiating hypertension treatment during cancer therapy.

Factors Affecting Employment Participation in Early-stage Breast Cancer

Researchers conducted a multivariate analysis to determine the factors that contribute to employment participation among women with early-stage breast cancer.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs